FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to using 1-(2-fluorobiphenyl-4-yl)-alkylcarboxylic acid derivatives as agents able to stabilise the tetramer native condition of transthyretin for preventing and treating amyloidosis.
EFFECT: producing the agent for preventing and treating amyloidosis.
10 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW TRANSTHYRETIN-RELATED AMYLOIDOSIS THERAPY | 2012 |
|
RU2623062C2 |
| NEW THERAPY OF TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS | 2012 |
|
RU2747536C2 |
| RNAI AGENTS, COMPOSITIONS AND METHODS FOR USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES | 2012 |
|
RU2678807C2 |
| MODULATION OF EXPRESSION OF TRANSTHYRETIN | 2011 |
|
RU2592669C2 |
| CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)BENZOXAZOLE | 2015 |
|
RU2692252C2 |
| TRANSTHYRETIN STABILISATION | 2005 |
|
RU2371440C2 |
| SOLID FORMS OF TRANSTHYRETIN DISSOCIATION INHIBITOR | 2012 |
|
RU2586330C2 |
| USE OF 4'-IODO-4'-DEOXYDOXORUBICINE FOR TREATMENT OF PATIENTS WITH AMYLOIDOSIS, METHOD OF TREATMENT OF PATIENTS WITH AMYLOIDOSIS | 1994 |
|
RU2155589C2 |
| SUBSTITUTED N-ARYLBENZAMIDES AND RELATED COMPOUNDS FOR TREATING AMYLOID DISEASES AND SYNUCLEINOPATHY | 2005 |
|
RU2381213C2 |
| APPLICATION OF ANTIBODY AGAINST AMYLOID-BETA IN CASE OF EYE DISEASES | 2008 |
|
RU2571859C2 |
